CIBC Private Wealth Group
ITCI

CIBC Private Wealth Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

CIBC Private Wealth Group’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-19
Closed -$1.57K – 3297
2024
Q4 		$1.57K Buy
+19
New +$1.56K ﹤0.01% 2736
2024
Q3 		– Sell
-25
Closed -$1.79K – 3325
2024
Q2 		$1.79K Sell
25
-9
-26% -$624 ﹤0.01% 2784
2024
Q1 		$2.32K Sell
34
-8,566
-100% -$589K ﹤0.01% 2719
2023
Q4 		$616K Hold
8,600
– – ﹤0.01% 746
2023
Q3 		$448K Buy
+8,600
New +$501K ﹤0.01% 781
2018
Q2 		– Sell
-10,200
Closed -$215K – 2116
2018
Q1 		$215K Buy
+10,200
New +$199K ﹤0.01% 920

Other funds holding ITCI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $14.1B AUM 58.13% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $7.94B AUM 55.6% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
DKCM
Davidson Kempner Capital Management New York $4.65B AUM 56.47% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.37B AUM 63.08% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return